Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-019891

Director bought 3,000 shares at $3.57 ($10,710)

From the SEC's structured data for this filing

Trades in this filing

ASELAGE STEVE · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-05-22 Purchase : show line 1 in the form +3,000 $3.57 $10,710 5,000 D
Open-market purchases · 3,000 sh · avg $3.57 · $10,710
Loading xslF345X03/form4.xml…